삼백초 추출물이 뼈 파괴세포 분화에 미치는 효과
Effect of Saururus Chinensis in RANKL-induced Osteoclast Differentiation
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Balance between bone-forming osteoblasts and bone-resorbing osteoclasts is important in bone homeostasis. Unusual balance between bone-forming osteoblasts and bone-resorbing osteoclasts leads to bone diseases, such as osteoporosis. Saururus chinensis has been widely used in oriental medicine. Saururus chinensis has been known that has antioxidant and anticancer effect. But, the effect of Saururus chinensis in osteoclast differentation remains unknown. We examined the effect of Saururus chinensis in receptor activator of nuclear factor-kB ligand (RANKL)-induced osteoclast differentiation. From the results of our study, we found that saururus chinensis clearly inhibited RANKL-induced osteoclast differentiation in bone marrow macrophages (BMM) in a dose dependent manner without toxicity. Saururus chinensis inhibited the phosphorylation of JNK, P38, AKT, and ERK induced by RANKL. The mRNA expression of NFATc1, TRAP, and OSCAR induced by RANKL was inhibited by Saururus chinensis treatment. Moreover Saururus chinensis suppressed the protein expression of c-Fos and NFATc1 in BMMs treated with RANKL. These results suggest that Saururus chinensis may be a useful drug in the treatment of bone-related disease.
Abstract
Balance between bone-forming osteoblasts and bone-resorbing osteoclasts is important in bone homeostasis. Unusual balance between bone-forming osteoblasts and bone-resorbing osteoclasts leads to bone diseases, such as osteoporosis. Saururus chinensis has been widely used in oriental medicine. Saururus chinensis has been known that has antioxidant and anticancer effect. But, the effect of Saururus chinensis in osteoclast differentation remains unknown. We examined the effect of Saururus chinensis in receptor activator of nuclear factor-kB ligand (RANKL)-induced osteoclast differentiation. From the results of our study, we found that saururus chinensis clearly inhibited RANKL-induced osteoclast differentiation in bone marrow macrophages (BMM) in a dose dependent manner without toxicity. Saururus chinensis inhibited the phosphorylation of JNK, P38, AKT, and ERK induced by RANKL. The mRNA expression of NFATc1, TRAP, and OSCAR induced by RANKL was inhibited by Saururus chinensis treatment. Moreover Saururus chinensis suppressed the protein expression of c-Fos and NFATc1 in BMMs treated with RANKL. These results suggest that Saururus chinensis may be a useful drug in the treatment of bone-related disease.
참고문헌 (19)
- Rodan, G. A., "Therapeutic approaches to bone diseases", Science, 289(5484), pp.1508~1541 (2000)
- Johnell, O., "An estimate of the worldwide prevalence and disability associated with osteoporotic fractures", Osteoporos Int, 17, pp.1726~ (2006)
- Goltzman, D, "Discoveries, drugs and skeletal disorders", Nat Rev Drug Discov, (10), pp.784~796 (2002)
- Roodman, G. D, "Regulation of osteoclast differentiation", Ann N Y Acad Sci, 1068, pp.100~109 (2006)
- Takayanagi, H, "Osteoimmunology: shared mechanisms and cross talk between the immune and bone systems", Nat. Rev. Immunol, 7, pp.292~304 (2007)
- Abrahamsen, B, "Bisphosphonate adverse effects, lessons from large databases", Curr Opin Rheumatol, 22(4), pp.404~409 (2010)
- 서부일, "韓藥本草學", pp.433~434, 영림사
- 강창수, "삼백초(Saururus chinensis) 추출물의 항산화능 및 생리활성 연구", 생명과학회지, 22(6), pp.807~814 (2012), 한국생명과학회
- Han, S. Y., "Korean journal of oriental preventive medical society", Korean journal of oriental preventive medical society, 7(2), pp.97~106 (2003)
- Korczowska, I, "Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients", Clin Rheumatol, 27(5), pp.565~572 (2008)
- Yarom, N., "Osteonecrosis of the jaw induced by orally administered bisphosphonates : incidence, clinical features, predisposing factors and treatment outcome", Osteoporos Int, 18(10), pp.1363~1370 (2007)
- Ikeda, F., "Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity", J Immunol, 177(4), pp.2384~2390 (2006)
- Dougall, W. C., "RANK is essential for osteoclast and lymph node development", Genes & Development, 13, pp.2412~2424 (1999)
- H. Takayanagi, "T. Taniguchi Developmental Cell", T. Taniguchi Developmental Cell, 3, pp.889~ (2002)
- M. Matsumoto, "The Journal of Biological Chemistry", The Journal of Biological Chemistry, 279, pp.45969~ (2004)
- Darnay, B. G., "Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappaB and c-Jun N-terminal kinase", J Biol Chem, 273, pp.20551~20555 (1998)
- Wong, B. R., "The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor", J Biol Chem, 273, pp.28355~28359 (1998)
- Partington, G. A., "1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation", Bone, 34, pp.237~245 (2004)
- Shimizu, H., "NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts", Gene Ther, 13(12), pp.933~941 (2006)